Michel Crepin

Title: Michel Crepin: Innovator in Pharmaceutical and Genetic Research

Introduction

Michel Crepin is a notable inventor based in Paris, France. He has made significant contributions to the fields of pharmaceuticals and genetic research. With a total of 2 patents, his work focuses on innovative solutions for medical applications.

Latest Patents

One of his latest patents is titled "Bisphosphonate derivatives, their preparations and uses." This invention relates to derivatives of 1-hydroxymethylene-1,1-bisphosphonic acid, which are used in pharmaceutical compositions for therapeutic applications, particularly in the treatment of cancerous tumors. The patent also outlines methods for preparing these derivatives. Another significant patent is "Process and reagents for the detection of a monocaternary nucleic acid." This invention describes a process for the in vitro detection of specific RNA, especially mRNA associated with genetic abnormalities in biological materials. The process involves treating cells to release their components while preserving the integrity of other nucleic acids, followed by a detection operation that utilizes a complementary nucleotidic sequence.

Career Highlights

Throughout his career, Michel Crepin has worked with prestigious institutions such as Institut Pasteur and Université Paris 13. His research has contributed to advancements in both pharmaceutical and genetic fields, showcasing his commitment to innovation and scientific progress.

Collaborations

Michel has collaborated with notable colleagues, including Marc Lecouvey and Yves Leroux. These partnerships have further enriched his research and development efforts.

Conclusion

Michel Crepin stands out as an influential inventor whose work in pharmaceuticals and genetic research has the potential to impact medical treatments significantly. His innovative patents reflect his dedication to advancing science and improving healthcare solutions.